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e syntheAbstract In this study, we describe a green and simple procedure for biosynthesis of ZnO nanopar-
ticles using Candida albicans as eco-friendly reducing and capping agent. The synthesized ZnO nano-
particles were characterized by UV–vis spectroscopy, powder X-ray diffraction, scanning electron
microscopy (SEM), transmission electronmicroscopy (TEM), photoluminescence (PL), thermogravi-
metric analysis (TGA) and differential thermal analysis (DTA). The prepared nano-particles were
used as catalyst for the fast and efﬁcient synthesis of steroidal pyrazolines (4–9) from a, b-unsaturated
steroidal ketones (1–3). The target molecules were obtained in good to excellent yields applying the
current method.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Green chemistry can be recognized as pioneering research,
which widely reports intrinsic atom economy, energy savings,
waste reduction, easy work ups and the avoidance of hazardous
chemicals (Kumar et al., 2012). The development of a simple,
eco-friendly reaction protocol for the synthesis of highly func-
tionalized compound libraries of medicinal motifs is an attrac-1003465.
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Saud University.
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sis of steroidal pyrazolines. Ative area of research in both academia and the pharmaceutical
industry (Domling, 2006). Nano-chemistry is an up growing re-
search area due to its unique properties (Xia et al., 2003). The
usage of nanomaterials as catalyst has gained a signiﬁcant role
in organic synthesis due to simple work-up procedure, environ-
mentally benign nature, reusability, low cost, and ease of isola-
tion. Recently, nano-crystalline inorganic oxides exhibited
enormous opportunities and attracted the interest of several re-
search groups because of their different topical characteristics
and wide range of particle sizes (Hadjipanayis and Siegel,
1994). Of late, catalysis by nanomaterials has become an area
of interest, as these materials exhibit better catalytic activity
compared to their bulk sized counterparts (Beydoun et al.,
1999; Zhang et al., 2007). Zinc oxide as a non-toxic, inexpensive,
and non-hygroscopic polar inorganic crystalline material is very
economical, safe, and easily available Lewis acid catalyst, which
has gained much interest in various organic transformations,ing Saud University.
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2 Shamsuzzaman et al.sensors, piezoelectrics, transparent conductors, and surface-
acoustic-wave devices (Bahrami et al., 2011; Tayebee et al.,
2010; Chanaewa et al., 2012; Hosseini et al., 2008; Jayaraj
et al., 2000; Gorla et al., 1999). Zinc oxide nano-particles have
very different physical and chemical properties compared to
the bulkmaterial (Kim andVarma, 2004). The induced catalytic
performance of nano-sized ZnO with reference to the commer-
cial analog in catalysis could be a result of the increased surface
area and changes occurred in surface properties. Therefore,
nano-ZnO has been potentially utilized as a heterogeneous cat-
alyst for various organic reactions (Mascolo et al., 2005; Mog-
haddam et al., 2008). Pyrazolines are an interesting group of
compounds, many of which possess wide spread pharmacologi-
cal properties such as analgesic, antipyretic and antiandrogenic
activities (Jung et al., 2005; Amr et al., 2005). Pyrazolines also
possess antidepressant, anti-inﬂammatory, antirheumatic, anti-
diabetic and antitumor activities (Havrylyuk et al., 2012; Ahn
et al., 2004; Bansal et al., 2001; Palaska et al., 2001; Hammam
et al., 2000). In the view of considerable importance of pyrazo-
line derivatives, several protocols have been developed for the
synthesis of these scaffolds over a period of time. The conven-
tional methods reported in the literature have their own advan-
tages but also suffer fromsomebottlenecks, such as use of acidic/
basic catalyst, modest yields, low reaction rate and tedious
work-up procedure (Karthikeyan et al., 2007; Bashir et al.,
2011; Rathish et al., 2009; Amir et al., 2008). Therefore, these
drawbacks prompted us to examine a new catalyst for the envi-
ronmentally benign synthesis of steroidal pyrazoline derivatives.
Inspired by the above catalytic activity of ZnOnanoparticles, we
examined the ZnO nanoparticles as a heterogeneous catalyst in
the synthesis of steroidal pyrazoline derivatives. We, in continu-
ation of our program on the synthesis of new steroidal heterocy-
les (Shamsuzzaman et al., 2013), aimed to investigate a very
facile, efﬁcient and high yielding new protocol for the synthesis
of steroidal pyrazoline derivatives (4–9) employed by the union
of cholest-5-en-7ones (1–3), and hydrazine hydrate/phenyl
hydrazine hydrate in the presence of ZnO nanoparticles as an
environmentally benign andheterogeneous catalyst under reﬂux
conditions.Although there are reports about the synthesis of ste-
roidal pyrazolines (Abdalla et al., 2012; Ivanyi et al., 2012; Cho-
udhary et al., 2011), no literature precedants were found
describing the synthesis of steroidal pyrazolines through the
strategy we have employed. The structure of the synthesized
compounds has been established on the basis of their elemental
analysis and spectral data. UV–vis spectroscopy, XRD, SEM,
TEM, PL, TGA and DTA have been used to characterize the
structure and morphology of the catalyst.
2. Experimental
2.1. General experimental
All the chemicals used were purchased from Sigma Aldrich
and Merck as analytical grade. The solvents were puriﬁed
prior to use. Zinc oxide nanoparticles were prepared by bio-
logical method from Candida albicans. The optical absor-
bance spectra were taken by using UV–vis double beam
Perkin–Elmer LAMDA 35 spectrophotometer at room tem-
perature in the wavelength range of 250–800 nm. X-ray dif-
fraction (XRD) patterns of the samples were obtained at
room temperature, with a step of 0.02, using Bruker D8 AD-
VANCE X-ray diffractometer with Cu Ka radiationPlease cite this article in press as: Shamsuzzaman, et al., Biological sy
catalytic performance in the synthesis of steroidal pyrazolines. A
j.arabjc.2013.05.004(k= 1.54178 ) in the range of 0 6 2h 6 100 at 40 kV.
SEM images were obtained using a ﬁeld emission scanning
electron microscope (JSM-7600F, JEOL, Tokyo Japan) at
an accelerating voltage of 15 kV and TEM images were ob-
tained with ultra-high resolution FETEM (JEOL, JEM-
2100F) at an accelerating voltage of 200 kV. Photolumines-
cence (PL) spectra were measured using a Cary Eclipse
EL06063917 ﬂuorescence spectrophotometer with a xenon
arc lamp as the light source. The thermal studies were carried
out using TGA/DTA-60H instrument (SHIMADZU) at a
heating rate of 20 C min1. Melting points were recorded
on Riechert Thermover instrument and are uncorrected. IR
spectra (KBr disks) were recorded on Interspec 2020 FT-IR
Spectrometer Spectro Lab and only noteworthy absorptions
were noted, its values are given in cm1. 1H and 13C NMR
spectra in dilute CDCl3 solutions at 303 K were run on a
Bruker Avance DRX 500 NMR spectrometer equipped with
a 5 mm diameter broad band inverse probehead working at
500 MHz for 1H and at 125 MHz for 13C, respectively. 1H
chemical shifts were referenced to the trace signal of CHCl3
(7.26 ppm from int. TMS). Following abbreviations were
used to indicate the peak multiplicity s -singlet, d - doublet,
t - triplet, m - multiplet and values are given in parts per mil-
lion (ppm) (d) and coupling constants (J) are given in Hertz
and 13C chemical shifts to the center peak of the solvent sig-
nal (77.00 ppm from int. TMS). Mass spectra were recorded
on a JEOL D-300 mass spectrometer. Elemental analyses
were carried out by the instrumentation lab at the Depart-
ment of Chemistry, Indian Institute of Technology Roorkee,
Roorkee, India within 0.04% of the theoretical values. The
progress of all reactions was monitored by thin layer chroma-
tography (TLC) plates with 0.5 mm layer of silica gel G, light
petroleum ether refers to a fraction of b.p. 60–80 C, and ex-
posed to iodine vapors to check the purity as well as the pro-
gress of reaction. Sodium sulfate (anhydrous) was used as a
drying agent. All described compounds showed the character-
istic spectral data of cyclopentanoperhydrophenanthrene nu-
clei of cholestane series that were similar to those reported
in the literature (Bhacca and Williams, 1964). For the nomen-
clature of steroid derivatives we used the deﬁnitive rules for
the nomenclature of steroids published by the Joint Commis-
sion on the Biochemical Nomenclature (JCBN) of IUPAC.2.2. Synthesis of ZnO nanoparticles
The ZnO nanoparticles were prepared by using some modiﬁca-
tion in the methods (Jayaseelan et al., 2012). C. albicans cells
were allowed to grow as a suspension culture in sterile distilled
water containing nutrient broth media for 24 h and treated
with 1.0% NaCl. Twenty-ﬁve mL of culture was taken and di-
luted four times by adding 75 mL of sterile distilled water con-
taining nutrients. This diluted culture solution was again
allowed to grow for another 24 h. Twenty mL aqueous solu-
tion of 1 mM zinc oxide (ZnO) was added to the culture solu-
tion and it was kept at 30 C for 24 h until white deposition
starts to appear at the bottom of the ﬂask, indicating the initi-
ation of transformation. The culture solution was cooled and
allowed to incubate at room temperature in the laboratory
ambience. After 15 h, the culture solution was observed to
have distinctly makeable coalescent white clusters deposited
at the bottom of the ﬂask. The reaction mixture was subjectednthesis of ZnO nanoparticles using C. albicans and studying their
rabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/
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Biological synthesis of ZnO nanoparticles using C. albicans and studying their catalytic performance 3to centrifugation for 15 min. The resulting pellet was stored in
the dark until further used.
2.3. General procedure for synthesis of 5a-cholestano [5, 7-cd]
pyrazoline derivatives 4–9
A mixture of a, b-unsaturated steroidal ketones (Dauben and
Takemura, 1953) (1–3) (1 mmol), hydrazine hydrate
(1 mmol)/phenyl hydrazine hydrate and ZnO nanoparticles
catalyst (0.003 g), in ethanol (5 mL) was reﬂuxed for 3 h. The
progress of the reaction was followed by TLC. After comple-
tion of the reaction, the mixture was ﬁltered to remove the cat-
alyst and the ﬁltrate was taken in ether, washed with water and
dried over anhydrous sodium sulfate. Removal of solvent gave
the crude product which was recrystallized from methanol to
obtain the pure compounds.
2.4. Spectral data of the synthesized compounds
2.4.1. 3b-Acetoxy-5a-cholestano[5,7-cd]pyrazoline (4)
Yield (80%); mp. 137–139 C; Anal. Calcd for C29H48N2O2: C,
76.27, H, 10.59, N, 6.13; found; C, 76.24, H, 10.55, N, 6.9; IR
(KBr) m cm1 3270 (NH), 1736 (OCOCH3), 1655 (C‚N), 1265
(C–N), 1235 (C–O); 1H NMR (CDCl3, 500 MHz) d 5.3 (s, 1H,
NH), 4.7 (m, 1H, C3a-H, W ½= 15 Hz, A/B trans), 2.5 (s,
2H, C6-CH2), 2.03 (s, 3H, OCOCH3), 1.18 (s, 3H, C10-
CH3), 0.70 (s, 3H, C13-CH3), 0.97 & 0.83 (other methyl pro-
tons); 13C NMR (CDCl3, 125 MHz) d 172, 156, 74, 66,, 48,
47, 46, 43, 42, 41, 40, 39, 36, 35, 32, 31, 30, 29, 28, 27, 26,
25, 24, 23, 22, 21, 20, 19, 16. MS (EI): (m/z) 456 [M+].
2.4.2. 3b-Chloro-5a-cholestano[5,7-cd]pyrazoline (5)
Yield (82%); mp. 140–142 C; Anal. Calcd for C27H45ClN2: C,
74.87, H, 10.47, N, 6.47; found; C, 74.85, H, 10.48, N, 6.44; IR
(KBr) m cm1 3265 (NH), 1650 (C‚N), 1254 (C–N), 776 (C–
Cl); 1H NMR (CDCl3, 500 MHz) d 5.4 (s, 1H, NH), 3.9 (m,
1H, C3a-H, W ½= 17 Hz, A/B trans), 2.65 (s, 2H, C6-
CH2), 1.19 (s, 3H, C10-CH3), 0.75 (s, 3H, C13-CH3), 0.97 &
0.80 (other methyl protons); 13C NMR (CDCl3, 125 MHz) d
159, 64, 60.2, 48, 47, 46, 43, 42, 41, 40, 39, 36, 35, 32, 31, 30,
29, 28, 27, 26, 25, 24, 23, 22, 21, 19, 16; MS (EI): (m/z) 432/
434 [M+].
2.4.3. 5a-Cholestano[5,7-cd]pyrazoline (6)
Yield (82%); mp. 134–136 C; Anal. Calcd for C27H46N2: C,
81.34, H, 11.63, N, 7.03; found; C, 81.37, H, 11.66, N, 7.05; IR
(KBr) m cm1 3267 (NH), 1657 (C‚N),1268 (C–N); 1H NMR
(CDCl3, 500 MHz) d 5.2 (s, 1H, NH), 2.32 (s, 2H, C6-CH2),
1.19 (s, 3H, C10-CH3), 0.75 (s,3H, C13-CH3), 0.96 & 0.83 (other
methyl protons); 13CNMR (CDCl3, 125 MHz) d 157, 65, 48, 47,
46, 43, 42, 41, 40, 39, 36, 35, 32, 31, 30, 29, 28, 27, 26, 25, 24, 23,
22, 21, 20, 19, 16; MS(EI): (m/z) 398 [M+].3 0 0 4 0 0 5 0 0 6 0 0
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Figure 1 UV–visible spectra of ZnO nanoparticles.2.4.4. 3b-Acetoxy-20-pheny-5a-cholestano[5,7-cd]pyrazoline
(7)
Yield (80%); mp. 180–182 C; Anal. Calcd for C35H52N2O2: C,
78.90, H, 9.84, N, 5.62; found; C, 78.88, H, 9.82, N, 5.58; IR
(KBr) m cm1 1734 (OCOCH3), 1630 (C‚N), 1242 (C–N),
3130, 1564, 1394 (aromatic ring), 1239 (C–O); 1H NMR
(CDCl3, 500 MHz) d 7.30–7.34 (m, 2H), 7.1–7.2 (m, 2H), 6.9Please cite this article in press as: Shamsuzzaman, et al., Biological sy
catalytic performance in the synthesis of steroidal pyrazolines. A
j.arabjc.2013.05.004(m,1H), 4.6 (m, 1H, C3 a-H, W ½= 15 Hz, A/B trans),
2.32 (s, 2H, C6-CH2), 1.19 (s, 3H, C10-CH3), 0.75 (s, 3H,
C13-CH3), 0.96 & 0.83 (other methyl protons);
13C NMR
(CDCl3, 125 MHz) d 172,156, 145, 130, 129, 120, 116, 114,
74, 66, 48, 47, 46, 43, 42, 41, 40, 39, 36, 35, 32, 31, 30, 29,
28, 27, 26, 25, 24, 23, 22, 21, 20, 19, 16; MS(EI): (m/z) 532
[M+].
2.4.5. 3b-Chloro20-pheny-5a-cholestano[5,7-cd]pyrazoline (8)
Yield (76%); mp. 170–172 C; Anal. Calcd for C33H49ClN2: C,
77.84, H, 9.70, N, 5.50; found; C, 77.88, H, 9.72, N, 5.54; IR
(KBr) m cm1 1635 (C‚N), 3129, 1590, 1407 (aromatic ring)
1235 (C–N), 743 (C–Cl); 1H NMR (CDCl3, 500 MHz) d
7.31–7.32 (m, 2H), 7.1–7.2 (m, 2H), 6.8 (m,1H), 3.9 (m, 1H,
C3 a-H, W ½= 17 Hz, A/B trans), 2.32 (s, 2H, C6-CH2),
1.19 (s, 3H, C10-CH3), 0.75 (s,3H, C13-CH3), 0.96 &0.83
(other methyl protons); 13C NMR (CDCl3, 125 MHz) d 159,
146, 128, 126, 119, 115,114, 64, 60, 48, 47, 46, 43, 42, 41, 40,
39, 36, 35, 32, 31, 30, 29, 28, 27, 26, 25, 24, 23, 22, 21, 19,
16; MS(EI): (m/z) 508/510 [M+].
2.4.6. 20-Pheny-5a-cholestano[5,7-cd]pyrazoline (9)
Yield (70%); mp. 185–187 C; Anal. Calcd for C33H50N2: C,
83.84, H, 10.62, N, 5.90; found; C, 83.87, H, 10.66, N, 5.92;
IR (KBr) m cm11640 (C‚N), 3095, 1590, 1406 (aromatic
ring), 1233 (C–N); 1H NMR (CDCl3, 500 MHz) d 7.34–7.32
(m, 2H), 7.2–7.1 (m, 2H), 6.8 (m,1H), 2.32 (s, 2H, C6-CH2),
1.19 (s, 3H, C10-CH3), 0.75 (s,3H, C13-CH3), 0.96 & 0.83
(other methyl protons); 13C NMR (CDCl3, 125 MHz) d 157,
147, 131,130, 122, 115, 113, 65, 48, 47, 46, 43, 42, 41, 40, 39,
36, 35, 32, 31, 30, 29, 28, 27, 26, 25, 24, 23, 22, 21, 20, 19,
16; MS(EI): (m/z) 474 [M+].
3. Results and discussion
3.1. Characterization of catalyst
3.1.1. UV spectrophotometry study
The UV–vis absorption spectrum ﬁndings demonstrate a novel
technique for the preparation of ZnO nanoparticles (Fig. 1), by
dispersing ZnO nanoparticles in distilled water and using dis-
tilled water as the reference. An absorption peak focused at
381 nm (3.26 eV) was found, which is in good agreement with
the previous work (Ni et al., 2005).nthesis of ZnO nanoparticles using C. albicans and studying their
rabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/
Figure 4 TEM image of the ZnO nanoparticles.
Figure 3 SEM image of the ZnO nanoparticles.
4 Shamsuzzaman et al.3.1.2. XRD analysis
X-ray diffraction is taken in order to further conﬁrm ZnO
phase of the nanoparticles. The XRD patterns of the obtained
ZnO nanoparticles are shown in Fig. 2. Powder XRD of the
product was carried out with Cu Ka radiation
(k= 0.1540 nm), employing a scanning rate of 0.02 s1 and
2h ranges from 20 to 80 for ZnO. All the peaks of XRD
are very well matched with the hexagonal phase (wurtzite
structure) by comparison with the data from JCPDS card
No.89-7102 and no indication of a secondary phase. The
strong and narrow diffraction peaks indicate that the product
has good crystalline structure. The crystallite size of the nano-
particles was calculated using Debye Scherrer formula
D ¼ Kk=b cos h;
where, K is constant, k is the wavelength of employed X-rays
(1.54056 A˚), b is corrected full width at half maximum and h
is Bragg’s angle. The 2h value from the equation comes out
to be at 35.815 and therefore the calculated crystallite size of
the powder particles is about 25 nm.
3.1.3. SEM and TEM analysis
The conformation of the nanostructure morphology of ZnO
particles comes from the analysis of SEM and TEM micro-
graphs. SEM micrograph (Fig. 3) showed the average size of
nanoparticles between 15 and 25 nm.
The size and morphology of ZnO particles analyzed by
TEM is represented in Fig. 4. This image reveals that most
of the ZnO nanoparticles are quasi-spherical and their diame-
ter is about 20 nm. This result is in accordance with the value
calculated from the X-ray diffraction.
3.1.4. Photoluminescence analysis
The PL spectrum of ZnO nanoparticles consists of two emis-
sion peaks (Fig. 5). A weak deep-level emission at 2.3 eV in
the visible range is caused by a structural defect (Soares
et al., 2008). The other peak in the UV range at 3.04 eV which
can be explained by the direct combination of excitons through
an exciton–exciton collision process and the lower energy peak
in the asymmetric UV emission is associated with band-to-20 40 60 80 100
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Figure 2 XRD image of the ZnO nanoparticles. Figure 5 The PL spectrum of ZnO nanoparticles.
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Table 1 Effect of catalyst loading on the model reaction.
Entry Catalysts (mol%) Time (h) Yield (%)a
1 2.5 4 30
2 5 3 80
3 7.5 3 80
4 10 3 80
a Yields are related to isolated pure products.
Biological synthesis of ZnO nanoparticles using C. albicans and studying their catalytic performance 5acceptor transitions due to the large binding energy of ZnO
(Ha et al., 2000).
3.1.5. Thermal stability
The differential thermal analysis and thermo gravimetric anal-
ysis (DTA/TGA) have been performed on the
biosynthesis of ZnO nanoparticles. TGA curve in Fig. 6
indicates that the weight loss starts at 200 C because of
the evaporation of water, the major weight loss occurs between
340 and 550 C, which is around 40% of the original weight
due to the removal and decomposition of organic groups pres-
ent in the sample during the biosynthesis. No decomposition
or reaction occurs at temperatures above 700 C. The exother-
mic peak observed in the DTA plot as shown in Fig. 6 between
370 and 520 C illustrates the maxima at 435 C which exem-
pliﬁes the burn-out of organic composition. Apart from this,
no other exothermic or endothermic peak is present in DTA
curve.
3.2. The catalytic performance of ZnO in the synthesis of
steroidal pyrazolines
As expected, the catalytic system is inﬂuenced by various
reaction parameters, such as amount of the catalyst employed,
effect of catalyst and solvent system. 3b-Acetoxy cholest-5-en-
7-one and hydrazine hydrate in ethanol were selected as model
substrates for carrying out the optimization studies for synthe-
sis of steroidal pyrazolines.
3.2.1. Catalytic loading
The effect of catalyst loading on the synthesis of model reac-
tion was investigated by varying the catalyst amount from 0
to 10 mol% (Table 1).
It was found that 5 mol% of the catalyst was sufﬁcient to
get optimum yields in less reaction time while less than
5 mol% of the catalyst increased the reaction time. Use of
more than 5 mol% of the catalyst did not show any profound
effect on the reaction rate as well as the yield this may be
attributed to the coagulation of ZnO nanoparticles which de-Figure 6 TGA and DTA curves of ZnO nanoparticles.
Please cite this article in press as: Shamsuzzaman, et al., Biological sy
catalytic performance in the synthesis of steroidal pyrazolines. A
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yya et al., 2012).
3.2.2. Effect of solvent
We then tried to screen the reaction in various organic solvents
in order to optimize the reaction conditions using ZnO nano-
particles as catalyst (Table 2).
The solvent screening experiments revealed that the reac-
tion yield is dependent on the polarity and the coordinating
ability of the solvents. The polar solvents afforded better yield
than the nonpolar ones and the best result was obtained in eth-
anol in which ZnO nanoparticle catalyst worked most efﬁ-
ciently by phasing out of the desired product. In order to
investigate the scope of this reaction, a variety of different ste-
roidal compounds were subjected to this reaction (Scheme 1).
All the reactions proceeded smoothly and the reaction was
completed within 3 to 3.5 h to afford the products (4–9) in
excellent yields (75–82%).
3.2.3. Recyclability of catalyst
After completion of the model reaction in speciﬁed time, the
catalyst was recovered by ﬁltration, washed with dichloro-
methane and methanol and dried at 150 C for 4 h and used
for the subsequent cycle (Ghomi and Ghasemzadeh, 2012).
The results revealed that the catalyst exhibited good catalytic
activity up to ﬁve cycles (Table 3).
3.2.4. Superiority of ZnO nanoparticles over some other metal
oxide nanoparticles
Various catalysts were employed to evaluate the capability and
efﬁciency of the catalyst (Table 4). Initially, the model reaction
was performed in the absence of any catalyst and the reaction
proceeded very slowly and the expected product was in a very
small quantity (entry 1) and when the model reaction was
examined with MgO, CaO, Fe2O3 and Al2O3 nanoparticles
using 5 mol% of each catalyst separately the reaction took
longer time period for completion with lower yield of the prod-
uct (entry 2–5). With ZnO nanoparticles the reaction wasTable 2 Solvent screening for the model reaction.
Entry Solvent Yield (%)a
1 Acetonitrile 40
2 Methanol 75
3 DMSO 60
4 Toluene 30
5 Ethanol 80
a Yields are related to isolated pure products.
nthesis of ZnO nanoparticles using C. albicans and studying their
rabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/
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Scheme 1 Synthesis of 5a-cholestano [5, 7-cd] pyrazoline deriv-
atives over ZnO nanoparticles.
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Scheme 2 Proposed mechanism of the formation of 5a-cholest-
ano [5, 7-cd] pyrazoline derivatives catalyzed by ZnO
nanoparticles.
Table 3 Recycling study of catalyst for the model reaction.
Entry Time (h) Yield (%)a
1 3 80
2 3 80
3 3 80
4 3 80
5 3 80
6 6 50
a Yields are related to isolated pure products.
Table 4 The superiority of ZnO nanoparticles over some
other metal oxide nanoparticles.
Entry Catalysts Time (h) Yield (%)a
1 – 24 20
2 MgO 12 28
3 CaO 10 30
4 Fe2O3 6 32
5 Al2O3 6 53
6 ZnO 3 80
a Yields are related to isolated pure products.
6 Shamsuzzaman et al.accelerated and yield of the desired product was maximum
(Table 4, entry 6).
These observations may be explained by the HSAB (hard
and soft acid base) concept. Unlike Zn2+ which is a borderline
Lewis acid, all the rest of nanoparticles are classiﬁed as hard
Lewis acids and the ﬁrst step of the reaction is the formation
of intermediate by the interaction of Lewis acid catalyst with
rather soft Lewis base carbonyl group which was assumed to
be efﬁcient for ZnO nanoparticles than the other (Kantam
et al., 2012).
3.2.5. Proposed reaction pathway for the synthesis of steroidal
pyrazolines
With these excellent results in our hand, we are now in a posi-
tion to propose the mechanism of the reaction which involves
Michael addition and then intramolecular cyclization cata-
lyzed by ZnO nanoparticles as presented in Scheme 2. In the
ﬁrst step, ZnO nanoparticles increase the electrophilicity ofPlease cite this article in press as: Shamsuzzaman, et al., Biological sy
catalytic performance in the synthesis of steroidal pyrazolines. A
j.arabjc.2013.05.004the carbonyl group which in turn accelerates the Michael
addition step. At the time of cyclization, the particular catalyst
plays the key role where ZnO acts as a mild acid and activates
the ketone group by polarization (through coordination) and
hence facilitates the intramolecular nucleophilic attack by the
NH2 group leading to the ring closure which ultimately forms
the ﬁnal product and again the catalyst enters into the catalytic
cycle.
4. Conclusions
In conclusion, we have reported biological synthesis of ZnO
nanoparticles using C. albicans as a green, reusable, nontoxic
and inexpensive heterogeneous catalyst. The synthesized nano-
particles were used as catalyst for the fast and efﬁcient synthe-
sis of steroidal pyrazolines. The attractive features of this
protocol are simple reaction procedure, short reaction time
and easy products. To the best of our knowledge, this is the
ﬁrst report about the synthesis of steroidal pyrazolines using
nano metal oxide as a catalyst.Acknowledgements
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